HER2 Support Group Forums - View Single Post - The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bon

News · 02-25-2011, 03:50 AM

Amgen today announced the publication of results from a Phase 3 head-to-head trial that compared XGEVA to Zometa in preventing bone complications called skeletal-related events in 1,901 men with prostate cancer and bone metastases.

More...

02-25-2011, 03:50 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,958	The Lancet journal publishes XGEVA Phase 3 study results against prostate cancer, bon Amgen today announced the publication of results from a Phase 3 head-to-head trial that compared XGEVA to Zometa in preventing bone complications called skeletal-related events in 1,901 men with prostate cancer and bone metastases. More...